|
|
|
Volumn 177, Issue 5, 2001, Pages 269-270
|
|
Percutaneous radiotherapy plus brachytherapy and concurrent chemotherapy for patients with localized esophageal carcinoma--Radiation Oncology Group Study 9207;Perkutane Strahlentherapie plus Brachytherapie sowie zeitgleiche Chemotherapie für Patienten mit lokalisiertem Osophaguskarzinom--Ergebnisse der RTOG-9207-Studie.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
FLUOROURACIL;
ADENOCARCINOMA;
ARTICLE;
BRACHYTHERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
ESOPHAGUS TUMOR;
HUMAN;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
RADIATION DOSE FRACTIONATION;
RADIOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
SQUAMOUS CELL CARCINOMA;
ADENOCARCINOMA;
ANTIMETABOLITES, ANTINEOPLASTIC;
BRACHYTHERAPY;
CARCINOMA, SQUAMOUS CELL;
COMBINED MODALITY THERAPY;
DOSE FRACTIONATION;
ESOPHAGEAL NEOPLASMS;
FLUOROURACIL;
HUMANS;
RADIOTHERAPY;
|
|
EID: 0035349865
PISSN: 01797158
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
